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Generation and characterization of human induced pluripotent stem cell
lines from a familial Alzheimer's disease PSEN1 A246E patient and a non-
demented family member bearing wild-type PSEN1
Abstract
The induced pluripotent stem cell (iPSC) lines UOWi002-A and UOWi003-A were reprogrammed from
dermal fibroblasts via mRNA transfection. Dermal fibroblasts from a 56 year old female caucasian familial
Alzheimer's disease patient carrying A246E mutation in the PSEN1 gene (familial AD3, autopsy confirmed
Alzheimer's disease) and a 75 year old female non-demented control from the same family bearing the wild-
type PSEN1 A246 genotype were obtained from the Coriell Institute (AG06848 and AG06846, respectively).
The generated iPSCs were characterized and pluripotency was confirmed. The PSEN1 genotype was
maintained in both iPSC lines.
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A B S T R A C T
The induced pluripotent stem cell (iPSC) lines UOWi002-A and UOWi003-A were reprogrammed from dermal fibroblasts via mRNA transfection. Dermal fibroblasts
from a 56 year old female caucasian familial Alzheimer's disease patient carrying A246E mutation in the PSEN1 gene (familial AD3, autopsy confirmed Alzheimer's
disease) and a 75 year old female non-demented control from the same family bearing the wild-type PSEN1 A246 genotype were obtained from the Coriell Institute
(AG06848 and AG06846, respectively). The generated iPSCs were characterized and pluripotency was confirmed. The PSEN1 genotype was maintained in both iPSC
lines.
Resource table.
Unique stem cell lines
identifier
UOWi002-A
UOWi003-A
Alternative names of stem
cell lines
iPSC 6846.2 (UOWi002-A)
iPSC 6848.2 (UOWi003-A)
Institution Illawarra Health and Medical Research
Institute, University of Wollongong
Contact information of
distributor
Lezanne Ooi, lezanne@uow.edu.au
Type of cell lines iPSC
Origin Human
Cell source Dermal fibroblast
Clonal Single clone
Method of reprogramming Transgene free
Multiline rationale Family members, one demented
patient with a familial Alzheimer's
disease mutation and one non-
demented control
Gene modification No
Type of modification N/A
Associated disease Non-demented control (UOWi002-A)
Familial Alzheimer's disease
(UOWi003-A)
Gene/locus N/A (UOWi002-A)
PSEN1 A246E (UOWi003-A)
Method of modification N/A
Name of transgene or
resistance
N/A
Inducible/constitutive
system
N/A
Date archived/stock date 24/04/2018
Cell line repository/bank N/A
Ethical approval HE13/299 University of Wollongong
Human Research Ethics Committee
https://doi.org/10.1016/j.scr.2018.08.006
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Resource utility
These iPSC lines can be used as a familial Alzheimer's disease cell
line model and an escapee non-demented control from the same family.
Resource details
Dermal fibroblasts from a 56 year old female Alzheimer's disease
patient and a 75 year old female escapee from the same family (Nee
et al., 1983) were obtained from the Coriell Institute (AG06848 and
AG06846, respectively, Table 1). The StemMACS mRNA Reprogram-
ming kit (Miltenyi Biotec) was used to generate the iPSC lines
(UOWi003-A and UOWi002-A), following the manufacturer's instruc-
tions. The iPSC colonies were isolated and expanded as individual
clones. The A246E mutation in the PSEN1 gene was confirmed present
in the UOWi003-A cell line and absent in the UOWi002-A cell line
(Fig. 1A), consistent with the parental fibroblast lines. The selected
clone for each cell line showed a normal karyotype with no abnormality
detected in 15 cells at 400 bands per haploid set for either of the iPSC
lines (Fig. 1B), and showed normal iPSC morphology (Fig. 1C). The
iPSC lines were authenticated against their respective fibroblast lines
via short tandem repeat (STR) profiling. Characterization of the clones
was carried out by immunostaining, showing expression of the plur-
ipotent markers Oct4 and SSEA-4 (Fig. 1C) and quantitative RT-PCR
(qRT-PCR) showed increased mRNA expression of the pluripotent genes
POU5F1 by> 4000 fold and NANOG by 100 fold (Fig. 1D) in the iPSCs
in comparison to their parental fibroblasts. Pluripotency was confirmed
via PluriTest (Müller et al., 2011), with the UOWi002-A and UOWi003-
A lines obtaining a Pluripotency Score of 24.16 and 18.64, respectively
and a Novelty Score of 1.46 and 1.47, respectively (Fig. 1E). Differ-
entiation potential of UOWi002-A and UOWi003-A was confirmed by
differentiation into endodermal, mesodermal or ectodermal lineages.
cDNA from each lineage was pooled in a 1:1:1 ratio and analysed using
TaqMan hPSC Scorecard. Results showed upregulation of specific genes
of the endoderm, mesoderm and ectoderm layer, while pluripotent
genes were downregulated (Fig. 1F). (See Table 2.)
Materials and methods
Reprogramming of dermal fibroblasts into iPSCs
Fibroblasts were plated on Matrigel-coated plates (Corning) and
cultured in Stemgent Pluriton Reprogramming Medium before repro-
gramming was carried out with the StemMACS mRNA Reprogramming
kit (Miltenyi Biotec, #130-104-460). After daily mRNA transfection for
11 days, the iPSC colonies that appeared in the cultures were manually
transferred to another Matrigel-coated plate for isolation and expan-
sion, and maintained in TeSR-E8 (Stemcell Technologies) at 37 °C and
5% CO2. This study was approved by the University of Wollongong
Human Research Ethics Committee (HE13/299).
Sequencing
DNA was extracted using the ISOLATE II Genomic DNA Kit (Bioline)
and amplified by PCR using MyTaq HS DNA Polymerase (Bioline) with
PSEN1 primers (Table 3). Sequencing reactions were performed using
ABI BigDye Terminator v3.1 Ready Reaction Mix, separated using
3500xL Genetic Analyzer (Applied Biosystems) and analysed using
BioEdit (Fig. 1A).
Karyotyping
Karyotyping of the iPSCs was performed by Sullivan Nicolaides
Pathology Pty Ltd. (Bowen Hills, Australia) (Fig. 1B).
Immunofluorescence staining
iPSC colonies were fixed with 4% paraformaldehyde for 10min and
permeabilized with 0.05% Triton-X for 15min. Blocking was performed
by incubation with 5% goat serum for 1 h at 22 °C and primary anti-
bodies (Table 3) were incubated overnight at 4 °C. Samples were in-
cubated with secondary antibody (Table 3) for 1 h at 22 °C followed by
RedDot2 (1:200, Biotium) or Hoescht 33,342 (1 μg/ml, Life Technolo-
gies) for 10min. Images were captured on a confocal microscope (Leica
DMI6000B) and acquired using LAS AF software (Leica Microsystems)
(Fig. 1C).
Quantitative reverse transcription polymerase chain reaction
mRNA was extracted using TriReagent (MRC Gene), DNA was re-
moved using Turbo DNAse kit (ThermoFisher Scientific) and cDNA was
generated using Tetro Reverse Transcriptase (Bioline) as per manufac-
turer's instructions. POU5F1 and NANOG expression was assessed in
triplicate using SensiFast SYBR (Bioline) on Corbett RotorGene3000
(ThermoFisher Scientific), using GAPDH and HPRT1 housekeeper genes
(Fig. 1D, Table 3). The efficiency of each sample was determined using
LinRegPCR (Ruijter et al., 2009) and analysis was performed using the
ΔΔCt method.
PluriTest
mRNA was analysed using Illumina HT 12v4 gene expression mi-
croarray via PluriTest (Müller et al., 2011) (Fig. 1E).
TaqMan hPSC scorecard
Direct differentiation of iPSC colonies to the three germ layers was
performed. Endoderm was induced with STEMdiff Definitive Endoderm
Kit (Stemcell Technologies). Mesoderm was induced using Mesoderm
base medium (DMEM/F12, 0.5% FBS, 1% GlutaMAX, 1% MEM Non-
essential aminoacids, 55 μM 2-mercaptoethanol, 45 μM ascorbic acid)
with 100 ng/ml Activin A (only on day 1), 10 ng/ml FGF-2, 100 ng/ml
BMP4 and 100 ng/ml VEGF for 7 days. Ectoderm was induced using
Neural induction medium (DMEM/F12, 0.4% B27, 1% N2, 1%
GlutaMAX, 1% MEM Non-essential aminoacids) with 1 μM LDN193189
for 2 days as iPSC colonies, and 2 μM SB431542 and 3 μM CHIR99021
for 7 days as embryoid bodies. cDNA from each culture was mixed in a
1:1:1 ratio to analyse 1 μg by TaqMan hPSC Scorecard (ThermoFisher)
as per the manufacturer's instructions.
STR analysis
STR analysis of 18 locations was performed at Garvan Molecular
Genetics Institute (Darlinghurst, Australia).
Table 1
Summary of lines.
iPSC line names Abbreviation in figures Gender Age Ethnicity Genotype of locus Disease
UOWi002-A UOWi002-A Female 75 Caucasian, Canadian PSEN1 A246 Non-demented control
UOWi003-A UOWi003-A Female 56 Caucasian, Canadian PSEN1 A246E Familial Alzheimer's disease
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Fig. 1. Characterization of iPSC lines UOWi002-A and UOWi003-A.
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Appendix A. Supplementary data
Supplementary data to this article can be found online at https://
doi.org/10.1016/j.scr.2018.08.006.
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Table 2
Characterization and validation.
Classification Test Result Data
Morphology Photography Normal Fig. 1C
Phenotype Immunocytochemistry Expression of pluripotency markers Oct4 and SSEA-4 Fig. 1C
RT-qPCR Cells express POU5F1 and NANOG Fig. 1D
Genotype Karyotype (G-banding) and resolution 46XX, resolution: 400 bph Fig. 1B
Identity Microsatellite PCR (mPCR) OR STR
analysis
N/A N/A
18 sites tested, matched Submitted in archive with
journal
Mutation analysis (IF
APPLICABLE)
Sequencing Yes – mutation present in UOWi003-A and absent in UOWi002-A Fig. 1A
Southern Blot or WGS N/A N/A
Microbiology and virology Mycoplasma Luminescence, negative Supplementary file 2
Differentiation potential PluriTest Pluripotency score: UOWi002-A=24.16 UOWi003-A=18.64
Novelty score: UOWi002-A=1.46 UOWi003-A=1.47
Fig. 1E
TaqMan hPSC scorecard Passed Fig. 1F
Donor screening (OPTIONAL) HIV 1+2 Hepatitis B, Hepatitis C N/A N/A
Genotype additional info
(OPTIONAL)
Blood group genotyping N/A N/A
HLA tissue typing N/A N/A
Table 3
Reagents details.
Antibodies used for immunocytochemistry/flow-citometry
Antibody Dilution Company Cat # and RRID
Pluripotency markers OCT4 1:500 Stemcell Technologies Cat# 01550, RRID: AB_1118539
SSEA4 1:200 Abcam Cat# ab16287, RRID: AB_778073
Secondary antibodies Alexa Fluor 488 Goat anti-mouse IgG (H+ L) 1:1000 Thermofisher Scientific Cat# A11001, RRID: AB_2534069
Primers
Target Forward/reverse primer (5′-3′)
Sequencing PSEN1 Forward: GGGAGCCATCACATTATTC
Reverse: CCTGTGACAAACAAATTATCAG
Pluripotency genes (qPCR) NANOG Forward: CCAGAACCAGAGAATGAAATC
Reverse: TGGTGGTAGGAAGAGTAAAG
POU5F1 Forward: GATCACCCTGGGATATACAC
Reverse: GCTTTGCATATCTCCTGAAG
House-keeping genes (qPCR) GAPDH Forward: GAGCACAAGAGGAAGAGAGAGACCC
Reverse: GTTGAGCACAGGGTACTTTATTGATGGTACATG
HPRT1 Forward: TGACACTGGCAAAACAATGCA
Reverse: GGTCCTTTTCACCAGCAAGCT
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